>
pdufa.bio

XMAB20717

Updated ยทnext FDA decision on the calendar

XMAB20717 is a Xencor Inc program. Its next catalyst is a Readout in Dec 2026. Every date links its source.

XNCR catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Xencor Inc (XNCR). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Dec 2026XNCR

Questions

When is XMAB20717's next FDA decision or readout?

The next tracked catalyst for XMAB20717 is a Readout in Dec 2026.

What happened at XMAB20717's most recent FDA decision?

No FDA decision for XMAB20717 is in our archive yet.

Who makes XMAB20717?

Xencor Inc (XNCR).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.